SI1957630T1 - Izboljšana proizvodnja glikoproteinov z uporabo mangana - Google Patents

Izboljšana proizvodnja glikoproteinov z uporabo mangana

Info

Publication number
SI1957630T1
SI1957630T1 SI200632055T SI200632055T SI1957630T1 SI 1957630 T1 SI1957630 T1 SI 1957630T1 SI 200632055 T SI200632055 T SI 200632055T SI 200632055 T SI200632055 T SI 200632055T SI 1957630 T1 SI1957630 T1 SI 1957630T1
Authority
SI
Slovenia
Prior art keywords
glycoproteins
manganese
improved production
production
improved
Prior art date
Application number
SI200632055T
Other languages
English (en)
Other versions
SI1957630T2 (sl
Inventor
Christopher K. Crowell
Gustavo Grampp
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38051866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1957630(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of SI1957630T1 publication Critical patent/SI1957630T1/sl
Publication of SI1957630T2 publication Critical patent/SI1957630T2/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI200632055T 2005-12-08 2006-12-06 Izboljšana proizvodnja glikoproteinov z uporabo mangana SI1957630T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74888005P 2005-12-08 2005-12-08
PCT/US2006/046609 WO2007070315A2 (en) 2005-12-08 2006-12-06 Improved production of glycoproteins using manganese
EP06847508.6A EP1957630B2 (en) 2005-12-08 2006-12-06 Improved production of glycoproteins using manganese

Publications (2)

Publication Number Publication Date
SI1957630T1 true SI1957630T1 (sl) 2016-06-30
SI1957630T2 SI1957630T2 (sl) 2023-07-31

Family

ID=38051866

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200632055T SI1957630T2 (sl) 2005-12-08 2006-12-06 Izboljšana proizvodnja glikoproteinov z uporabo mangana

Country Status (7)

Country Link
US (7) US7972810B2 (sl)
EP (4) EP3026109B1 (sl)
AU (1) AU2006324163B2 (sl)
CA (1) CA2630811C (sl)
ES (2) ES2913277T3 (sl)
SI (1) SI1957630T2 (sl)
WO (1) WO2007070315A2 (sl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3026109B1 (en) 2005-12-08 2022-03-09 Amgen Inc. Improved production of glycoproteins using manganese
AU2016244316B2 (en) * 2006-07-13 2018-07-12 Wyeth Llc Production of glycoproteins
KR101495549B1 (ko) * 2006-07-13 2015-02-25 와이어쓰 엘엘씨 당단백질의 생산
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
NZ575328A (en) 2006-09-13 2012-06-29 Abbott Lab Cell culture improvements
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
EP2456871B1 (en) * 2009-07-24 2016-09-07 Dr. Reddy's Laboratories, Ltd. Production of erythropoiesis stimulating protein using metal ions
WO2011024024A1 (en) * 2009-08-28 2011-03-03 Avesthagen Limited A process for recovering darbepoeitin alfa isoforms
WO2011024025A1 (en) * 2009-08-28 2011-03-03 Avesthagen Limited An erythropoietin analogue and a method thereof
EP2325296A1 (en) 2009-11-20 2011-05-25 LEK Pharmaceuticals d.d. Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US10059770B2 (en) 2012-01-30 2018-08-28 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of a glycoprotein composition
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
CA2883272A1 (en) 2012-09-02 2014-03-06 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
KR20150133833A (ko) * 2013-03-26 2015-11-30 코히러스 바이오사이언시즈, 인코포레이티드 단백질 생산 방법
US9856502B2 (en) 2013-07-23 2018-01-02 Biocon Limited Methods for controlling fucosylation levels in proteins
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
RU2642285C1 (ru) * 2014-01-29 2018-01-24 ЭлДжи КЕМ, ЛТД. Способ получения целевого антитела с модулированным галактозилированием (варианты) и способ модулирования галактозилирования целевого антитела (варианты) путем оптимизации культуральной среды
LT3110961T (lt) * 2014-02-27 2020-02-10 F. Hoffmann-La Roche Ag Ląstelių augimo ir glikozilinimo moduliavimas, gaminant rekombinantinį glikoproteiną
WO2015140700A1 (en) * 2014-03-19 2015-09-24 Dr. Reddy's Laboratories Limited Cell culture process
KR101660580B1 (ko) * 2014-04-02 2016-09-28 프레스티지 바이오파마 피티이. 엘티디. 항체의 당 함량 조절을 통한 항체의 제조 방법
US20170226552A1 (en) * 2014-07-03 2017-08-10 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
US20160130324A1 (en) 2014-10-31 2016-05-12 Shire Human Genetic Therapies, Inc. C1 Inhibitor Fusion Proteins and Uses Thereof
EA202091598A3 (ru) 2014-12-01 2021-01-29 Эмджен Инк. Процесс контроля уровня содержания гликанов в составе
KR102007930B1 (ko) 2014-12-31 2019-08-06 주식회사 엘지화학 재조합 당단백질의 글리코실화 조절 방법
WO2016196621A1 (en) * 2015-06-01 2016-12-08 Biogen Ma Inc. Manganese supplementation for control of glycosylation in mammalian cell culture process
JP7189767B2 (ja) 2015-11-19 2022-12-14 武田薬品工業株式会社 組換えヒトｃ１エステラーゼインヒビター及びその使用
US10519479B1 (en) * 2016-03-15 2019-12-31 Ares Trading S.A. Methods for modifying glycosylation using manganese

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) † 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4667016A (en) 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification
AU646822B2 (en) 1989-10-13 1994-03-10 Kirin-Amgen Inc. Erythropoietin isoforms
DE4115722A1 (de) 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
IL192290A0 (en) 1993-08-17 2008-12-29 Kirin Amgen Inc Erythropoietin analogs
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5459031A (en) 1993-11-05 1995-10-17 Amgen Inc. Methods for controlling sialic acid derivatives in recombinant glycoproteins
US5888774A (en) † 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
IL118201A (en) 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ，インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
US7033774B2 (en) * 1997-04-21 2006-04-25 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
PT902085E (pt) 1997-09-01 2004-02-27 Aventis Pharma Gmbh Eritropoietina humana recombinante com perfil de glicosilacao vantajoso
US6537782B1 (en) * 1998-06-01 2003-03-25 Chugai Seiyaku Kabushiki Kaisha Media for culturing animal cells and process for producing protein by using the same
US7304150B1 (en) * 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
DK1123313T3 (da) 1998-10-23 2007-06-18 Amgen Inc Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
PT1171615E (pt) † 1999-04-26 2007-03-30 Genentech Inc Processo de cultura celular para glicoproteínas
EP1961425B1 (en) 2000-04-21 2017-07-19 Amgen Inc. Methods and erythropoeitin analogs for the prevention and treatment of anemia
EP1298217A4 (en) 2000-07-05 2004-09-08 Mitsubishi Pharma Corp GLYCOPROTEIN PRODUCTION PROCESS
DE102004007658B4 (de) 2004-02-17 2008-12-18 Bioceuticals Arzneimittel Ag Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen
DE102004027816A1 (de) 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
DE102005050580A1 (de) 2005-10-21 2007-04-26 Siegfried Biologics Gmbh Verfahren zur Charakterisierung der Qualität von Sialoglycoproteinen über eine Isoformenzahl I und dessen Verwendung
EP3026109B1 (en) 2005-12-08 2022-03-09 Amgen Inc. Improved production of glycoproteins using manganese
US9105867B2 (en) 2007-07-04 2015-08-11 Koninklijke Philips N.V. Method for forming a patterned layer on a substrate

Also Published As

Publication number Publication date
ES2913277T3 (es) 2022-06-01
AU2006324163A1 (en) 2007-06-21
EP4155385A1 (en) 2023-03-29
CA2630811C (en) 2016-05-31
US20140088294A1 (en) 2014-03-27
US9273110B2 (en) 2016-03-01
SI1957630T2 (sl) 2023-07-31
US20170355741A1 (en) 2017-12-14
US20220402986A1 (en) 2022-12-22
AU2006324163B2 (en) 2013-05-02
EP1957630A2 (en) 2008-08-20
CA2630811A1 (en) 2007-06-21
WO2007070315A2 (en) 2007-06-21
US20070161084A1 (en) 2007-07-12
EP2495308A1 (en) 2012-09-05
US7972810B2 (en) 2011-07-05
EP3026109A1 (en) 2016-06-01
US20110287483A1 (en) 2011-11-24
EP3026109B1 (en) 2022-03-09
EP1957630B1 (en) 2016-02-17
ES2564790T3 (es) 2016-03-29
ES2564790T5 (es) 2023-08-25
US8617878B2 (en) 2013-12-31
US20160222075A1 (en) 2016-08-04
EP1957630B2 (en) 2023-03-29
WO2007070315A3 (en) 2007-12-27
US20210047381A1 (en) 2021-02-18

Similar Documents

Publication Publication Date Title
SI1957630T1 (sl) Izboljšana proizvodnja glikoproteinov z uporabo mangana
HK1214307A1 (zh) 糖蛋白的產生
EP1899476A4 (en) CELLULASE PRODUCTION
IL181587A0 (en) Production of ??-abeta
EP1954815A4 (en) Preparation of Glycoproteins with Reduced O-Glycosylation
ZA200800562B (en) Efficient production of hydrogen
EP1851345A4 (en) FERRONICKEL PRODUCTION
PL1957656T3 (pl) Fermentacyjne wytwarzanie lizyny
GB0505064D0 (en) Production of bio-diesel
IL185757A0 (en) Methods of decreasing calcifcation
EP1793648A4 (en) LOUD SPEAKER
PL1931842T3 (pl) Zespół profili
GB0808916D0 (en) Production of conjugates
ZA200803555B (en) Manufacture of esters
EP1788840A4 (en) SPEAKER
GB0509720D0 (en) Configuration of VPNs
EP1860912A4 (en) SPEAKER
GB0623010D0 (en) Production of composite mouldings
EP1885868A4 (en) PREPARATION OF ENZYMES
GB0512150D0 (en) Production of L-ascorbic acid
PL1683617T3 (pl) Wytwarzanie paneli strukturalnych
EP1890865A4 (en) ROLL OF PAPER RIBBON
ZA200709947B (en) Production of hydrotalcite
TWM291553U (en) Improved structure of fan-free mini-computer
GB0508439D0 (en) Design of structural elements